Literature DB >> 16687484

MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases.

Martin Illemann1, Nigel Bird, Ali Majeed, Maxwell Sehested, Ole D Laerum, Leif R Lund, Keld Danø, Boye Schnack Nielsen.   

Abstract

Matrix metalloproteinase-9 (MMP-9) is up-regulated in macrophages in various human cancer types. In human colon cancer, MMP-9 is expressed in a macrophage subpopulation located at the tumor edge, indicating a specific induction of MMP-9 in macrophages in direct association with cancer invasion. To test whether MMP-9 is also induced in tumor edge macrophages in metastases from colorectal adenocarcinomas, we have compared the expression pattern of MMP-9 in primary colorectal adenocarcinomas (n = 15) with that in liver metastases (n = 15) and local lymph node metastases (n = 7) from the same patients by in situ hybridization and immunohistochemistry. In all the colorectal adenocarcinomas, the expression of MMP-9 mRNA and immunoreactivity in macrophages was located at the invasive front. In contrast, only 3 of the 15 liver metastases had MMP-9 mRNA and immunoreactivity at the periphery, and this expression was confined to small foci of macrophages located either among lymphocytes or in a dense desmoplastic stroma. Expression of MMP-9 mRNA and immunoreactivity was in all liver metastases seen in macrophages located in the lumen of malignant glandular structures and in central necrotic tissue. In all the 7 lymph node metastases, MMP-9 mRNA and immunoreactivity was seen in macrophages located in the stromal tissue surrounding the metastases. We conclude that MMP-9 is not up-regulated in tumor edge macrophages in liver metastases like in their primary tumor and local lymph node metastases, suggesting that disseminating colorectal cancer cells can adopt alternative proteolytic mechanisms for invasion depending on the local microenvironment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16687484     DOI: 10.1158/1541-7786.MCR-06-0003

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  37 in total

Review 1.  Immune cell interplay in colorectal cancer prognosis.

Authors:  Samuel E Norton; Kirsten A Ward-Hartstonge; Edward S Taylor; Roslyn A Kemp
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

Review 2.  Matrix-metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression.

Authors:  Kyle J Isaacson; M Martin Jensen; Nithya B Subrahmanyam; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

3.  Ribonucleotide reductase small subunit M2B prognoses better survival in colorectal cancer.

Authors:  Xiyong Liu; Lily Lai; Xiaochen Wang; Lijun Xue; Sofia Leora; Jun Wu; Shuya Hu; Keqiang Zhang; Mei-Ling Kuo; Lun Zhou; Hang Zhang; Yafan Wang; Yan Wang; Bingsen Zhou; Rebecca A Nelson; Shu Zheng; Suzhan Zhang; Peiguo Chu; Yun Yen
Journal:  Cancer Res       Date:  2011-03-17       Impact factor: 12.701

4.  The histological growth pattern of colorectal cancer liver metastases has prognostic value.

Authors:  Gert G Van den Eynden; Nigel C Bird; Ali W Majeed; Steven Van Laere; Luc Y Dirix; Peter B Vermeulen
Journal:  Clin Exp Metastasis       Date:  2012-04-03       Impact factor: 5.150

5.  The tumor microenvironment in colorectal carcinogenesis.

Authors:  Vijay G Peddareddigari; Dingzhi Wang; Raymond N Dubois
Journal:  Cancer Microenviron       Date:  2010-03-05

6.  p38gamma MAPK cooperates with c-Jun in trans-activating matrix metalloproteinase 9.

Authors:  Mathew Loesch; Hui-Ying Zhi; Song-Wang Hou; Xiao-Mei Qi; Rong-Shan Li; Zainab Basir; Thomas Iftner; Ana Cuenda; Guan Chen
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

7.  Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon.

Authors:  László Herszényi; Ferenc Sipos; Orsolya Galamb; Norbert Solymosi; István Hritz; Pál Miheller; Lajos Berczi; Béla Molnár; Zsolt Tulassay
Journal:  Pathol Oncol Res       Date:  2008-03-18       Impact factor: 3.201

8.  Growth and invasion of sporadic colorectal adenocarcinomas in terms of genetic change.

Authors:  Seon Ae Roh; Eun Young Choi; Dong Hyung Cho; Se Jin Jang; Seon Young Kim; Yong Sung Kim; Jin Cheon Kim
Journal:  J Korean Med Sci       Date:  2010-02-17       Impact factor: 2.153

9.  Extracellular matrix gene expression profiling using microfluidics for colorectal carcinoma stratification.

Authors:  Christopher J Hayes; Catriona M Dowling; Susan Dwane; Mary E McCumiskey; Shona M Tormey; B Anne Merrigan; John C Coffey; Patrick A Kiely; Tara M Dalton
Journal:  Biomicrofluidics       Date:  2016-10-31       Impact factor: 2.800

10.  Matrix metalloproteinase-9-1562C>T polymorphism may increase the risk of lymphatic metastasis of colorectal cancer.

Authors:  Li-Li Xing; Zhen-Ning Wang; Li Jiang; Yong Zhang; Ying-Ying Xu; Juan Li; Yang Luo; Xue Zhang
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.